Research and experimental development on natural sciences and engineering
IMMUNOQUEST THERAPEUTICS AS
Revenue 2024
NOK 0
Operating profit
NOK −718,000
Equity
NOK −721,000
Incorporated
2023
Share capital
NOK 43,000
Organisation
Established
2023-06-06
Industry code
72.100
Legal form
AS
Group structure
Eier · 60.0%
INVEN2 AS
Company
IMMUNOQUEST THERAPEUTICS AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Public incorporated enterprises, owned by central government
- Activity
- Forskning og utvikling av kreftbehandling.
Business address
Gaustadalléen 21, 0349 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.